A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis



Status:Recruiting
Conditions:Renal Impairment / Chronic Kidney Disease, Endocrine
Therapuetic Areas:Endocrinology, Nephrology / Urology
Healthy:No
Age Range:6 - 17
Updated:4/21/2016
Start Date:November 2014
End Date:December 2016
Contact:Amgen Call Center
Phone:866-572-6436

Use our guide to learn which trials are right for you!

A Randomized, Open-label, Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Dialysis

This is a phase 3, 24-week, randomized, multicenter, open-label, controlled study. subjects
will be randomized into one of two treatment arms; oral administration of cinacalcet daily
in addition to standard of care treatment arm or a standard of care arm. Randomization will
be stratified by age group. All subjects receive standard of care which can include therapy
with Vitamin D sterols, calcium supplementation, and phosphate binders.


Inclusion Criteria:

- Age 6 - < 18 years

- Diagnosis of SHPT with the mean of the two consecutive central laboratory iPTH values
≥ 300 pg/mL during screening

- Corrected calcium value of ≥ 8.8 mg/dL during screening

- Diagnosis of CKD, receiving either hemodialysis or peritoneal dialysis, for ≥ 30 days
prior to screening

- Parent or legally acceptable representative has provided written informed consent and
subject has provided written assent when required by institutional guidelines

Exclusion Criteria:

- History of congenital long QT syndrome, second or third degree heart block,
ventricular tachyarrhythmias or other conditions associated with prolonged QT
interval

- Corrected QT interval (QTc) > 500 ms, using Bazett's formula

- QTc ≥ 450 to ≤ 500 ms, using Bazett's formula, unless written permission to enroll is
provided by the investigator after consultation with a pediatric cardiologist

- Use of grapefruit juice, herbal medications, or potent CYP 3A4 inhibitors (eg,
erythromycin, clarithromycin, ketoconazole, itraconazole)

- Use of concomitant medications that may prolong the QTc interval (eg, ondansetron,
albuterol)
We found this trial at
27
sites
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Bronx, NY
Click here to add this to my saved trials
?
mi
from
Bruxelles,
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Greenville, North Carolina 27834
?
mi
from
Greenville, NC
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Iowa City, IA
Click here to add this to my saved trials
?
mi
from
Jackson, MS
Click here to add this to my saved trials
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Louisville, KY
Click here to add this to my saved trials
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
?
mi
from
West Orange, NJ
Click here to add this to my saved trials
?
mi
from
Wilmington, DE
Click here to add this to my saved trials